Secondary systemic lupus erythematosus: An analysis of 4 cases of uncontrolled hereditary angioedema

Clinical Immunology

Volumn 123, Issue 1, 2007, Pages 14-17

  Khan, Sujoy ^a,b   Tarzi, Michael D ^d   Doré, Philip C ^b   Sewell, W A C ^a,c   Longhurst, Hilary J ^d  

^a SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LINCOLN   (United Kingdom)

^d BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

AAE; Acquired angioedema; Apoptosis; Complement deficiency; HAE; Hereditary angioedema; Systemic lupus erythematosus

Indexed keywords

DANAZOL; TRANEXAMIC ACID;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; APOPTOSIS; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; COMPLEMENT C4; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 33947137687     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.09.015     Document Type: Article

References (17)

1. Gompels M.M., Lock R.J., Abinun M., Bethune C.A., Davies G., Grattan C., Fay A.C., Longhurst H.J., Morrison L., Price A., Price M., and Watters D. C1 inhibitor deficiency: consensus document. Clin. Exp. Immunol. 139 (2005) 379-394
2. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., and Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
3. Kohler P.F., Percy J., Campion W.M., and Smyth C.J. Hereditary angioedema and "familial" lupus erythematosus in identical twin boys. Am. J. Med. 56 (1974) 406-411
4. Sayama K., Shiraishi S., and Miki Y. Complement profile in a C1 inhibitor deficient family. Br. J. Dermatol. 113 (1985) 737-743
5. Koide M., Shirahama S., Tokura Y., Takigawa M., Hayakawa M., and Furukawa F. Lupus erythematosus associated with C1-inhibitor deficiency. J. Dermatol. 29 (2002) 503-507
6. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., and Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76 (2000) 227-324
7. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313-2320
8. Rosen A., and Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6 (1999) 6-12
9. Agostoni A., and Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 71 (1992) 206-215
10. Brickman C.M., Tsokos G.C., Balow J.E., Lawley T.J., Santaella M., Hammer C.H., and Frank M.M. Immunoregulatory disorders associated with hereditary angioedema: I. Clinical manifestations of autoimmune disease. J. Allergy Clin. Immunol. 77 (1986) 749-757
11. Ozbek S., Sert M., Paydas S., and Soy M. Delay in the diagnosis of SLE: the importance of arthritis/arthralgia as the initial symptom. Acta Med. Okayama 57 (2003) 187-190
12. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., and Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 (2003) 1526-1533
13. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344 (2001) 1140-1144
14. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
15. Cicardi M., Castelli R., Zingale L.C., and Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J. Allergy Clin. Immunol. 99 (1997) 194-196
16. Szeplaki G., Varga L., Valentin S., Kleiber M., Karadi I., Romics L., Fust G., and Farkas H. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J. Allergy Clin. Immunol. 115 (2005) 864-869
17. Hall F.C., and Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin?. Rheumatology (Oxford) 44 (2005) 1473-1482